Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
05/2010
05/13/2010US20100120015 Method of collecting placental stem cells
05/13/2010US20100119597 Multi-component pharmaceutical dosage form
05/13/2010US20100119593 Liposome and method for producing the same
05/13/2010US20100119579 Decellularized liver for repair of tissue and treatment of organ deficiency
05/13/2010US20100119575 Osteogenic composite matrix, method for the production thereof and implant and scaffold for tissue engineering provided with a coating formed by said osteogenic composite matrix
05/13/2010US20100119569 Systems for improving material exchange with an implant
05/13/2010US20100119555 Methods and Compositions for the Treatment and Diagnosis of Cancer
05/13/2010US20100119528 Transport of Biologically Active Molecules into a Cell, Mitochondrion, or Nucleus
05/13/2010US20100119521 Compositions and methods for treating cancer by modulating her-2 and egf receptors
05/13/2010US20100119502 Therapy regimens, dosing regimens and stable medicaments for the treatment of pompe disease
05/13/2010US20100119491 Dopaminergic neuronal survival-promoting factors and uses thereof
05/13/2010US20100119471 Mycoplasma hyopneumoniae bacterin vaccine
05/12/2010EP2184353A1 Treatment of influenza
05/12/2010EP2184282A1 Novel salt of isoquinoline compound and crystal thereof
05/12/2010EP2184281A1 Phenyl-thiophene type vitamin D receptor modulators
05/12/2010EP2184279A1 Pharmaceutical composition containing optically active compound having thrombopoietin receptor agonist activity and intermediate thereof
05/12/2010EP2184278A1 P2x4 receptor antagonist
05/12/2010EP2184272A1 Piperazine derivative
05/12/2010EP2184073A1 Therapeutic agent for cancer with resistance to protease inhibitor
05/12/2010EP2182936A2 Substrate reduction therapy
05/12/2010EP1564210B9 4-oxoquinoline compounds and utilization thereof as hiv integrase inhibitors
05/12/2010EP1373262B1 Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors
05/12/2010EP1173169B1 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof
05/12/2010CN201453509U External patch with moxibustion effect
05/12/2010CN1943653B An external latex membrane curing mouse hand and its preparation method
05/12/2010CN1939895B Compound, composition and method for preventing from neurodegeneration in injury of central nervous system
05/12/2010CN1915050B Ganoderma lucidum tea and processing technique
05/12/2010CN1907481B Medicinal composition for treating summer heat-dampness rheum and preparation method thereof
05/12/2010CN1899400B Detection method for injection containing ginseng and aconite root in raw material
05/12/2010CN1899387B Method for preventing and treating child convulsion and its preparing method
05/12/2010CN1840094B Preparation method of yin-nourishing fatigue-eliminating granule and capsule with micron oligosaccharide, American ginseng, lily, cactus, official dendrobium stem and royal jelly
05/12/2010CN1671856B Novel physiologically active substances
05/12/2010CN1646558B Histone deacetylase inhibitors and process for producing the same
05/12/2010CN1642929B Kappa-opioid receptor agonist comprising 2-phenylbenzothiazoline derivative
05/12/2010CN1642577B Preparation comprising buprenorphine
05/12/2010CN1642552B 4-(N-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors
05/12/2010CN1636994B Process of preparing alkali metal salys of hydrophobic sulfonamides and alkali metal salt produced thereby
05/12/2010CN1617715B Treating muscle wasting with selective androgen receptor modulators
05/12/2010CN1599750B Cytotoxic protein and utilization thereof
05/12/2010CN1537000B Novel imidazolidine derivatives, their preparation and their use as VLA-4 antagonists
05/12/2010CN1529587B Medicine bisacodyl granular composition comprising dung softening poloxamer and coated with enteric-coatel casing
05/12/2010CN101704797A compounds effecting glucokinase
05/12/2010CN101703777A Tamper-resistant oral opioid agonist formulations
05/12/2010CN101703761A Use of cntf (ciliary neurotrophic factor) receptor activators for the treatment of obesity
05/12/2010CN101703733A Medicament for treating tumor-like diseases
05/12/2010CN101703642A Compound preparation for promoting shedding and growth of shrimps and crabs and preparation method thereof
05/12/2010CN101703634A Medicament for treating cellulitis and preparation method thereof
05/12/2010CN101703630A Deodorant pills capable of making fragrance permeate body surface
05/12/2010CN101703553A Summer heat-clearing and toxin-resolving product for food and medicine purposes
05/12/2010CN101703509A Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activity
05/12/2010CN101703472A Granulating coated slow release product of cysteamine hydrochloride and preparation method thereof
05/12/2010CN101172116B Composition, preparing method and application of the same
05/12/2010CN101100453B Method for synthesizing ifenprodil tartrate
05/12/2010CN101019641B Process of producing black food containing plant melanin
05/12/2010CN100998818B Oral Chinese medicine for treating damp-heat impairment of yang night sweating
05/12/2010CN100998794B Oral administration Chinese medicine for treating lower wanner damp-heat night sweat
05/12/2010CN100998793B Oral traditional Chinese medicine for treating damp-heat and impairment of yin type serious sweat disease
05/11/2010US7714170 Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs; Alzheimer's disease; diabetes; A beta amyloidosis
05/11/2010US7714013 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents
05/11/2010US7714003 Imidazo[2,1-b ]-1,3,4-thiadiazole sulfonamides
05/11/2010US7713999 Thrombin receptor antagonists
05/11/2010US7713984 Pharmaceutical uses
05/11/2010US7713963 Acylated indanyl amines and their use as pharmaceuticals
05/11/2010US7713957 Pharmaceutical composition containing gabapentin or pregabalin and N-type calcium channel antagonist
05/11/2010US7713949 Compositions and methods for enhancing paracellular permeability across epithelial and endothelial barriers
05/11/2010US7713538 Drug delivery from stents
05/11/2010US7713529 Methods for treating and preventing infectious disease
05/11/2010CA2503663C Novel quinoxalinone derivatives
05/11/2010CA2462110C Phenyl-piperazine derivatives as serotonin reuptake inhibitors
05/11/2010CA2461958C Combination dosage form containing a cholesterol-lowering agent, a renin-angiotensin inhibitor, and aspirin
05/11/2010CA2422299C Triazole compounds useful as protein kinase inhibitors
05/11/2010CA2413134C Quinazoline ditosylate salt compounds
05/11/2010CA2412968C Substituted pyridines as selective cyclooxygenase-2 inhibitors
05/11/2010CA2410177C Thrombin receptor antagonists
05/11/2010CA2403871C Inhibition of angiogenesis and tumor growth
05/11/2010CA2400612C Oxy-and amino-substituted tetrahydrofuryl derivatives with antitumour activity
05/11/2010CA2335105C Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders
05/11/2010CA2326401C Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress
05/11/2010CA2318696C Triazepinones, process for their preparation and their therapeutic application
05/11/2010CA2294709C Compositions and methods for enhancing delivery of therapeutic agents to cells
05/11/2010CA2279517C Method and compositions for preventing and treating the systemic inflammatory response syndrome including sepsis
05/06/2010WO2010050586A1 Method for enhancing expression of recombinant protein
05/06/2010WO2010050584A1 Method for selectively controlling function of helper t cell
05/06/2010WO2010050528A1 Anti-muc1 antibody
05/06/2010WO2010050525A1 Compound having tafia inhibitory activity
05/06/2010WO2010050513A1 Polypeptide having function to increase calcium concentration in osteoblast
05/06/2010WO2010050445A1 Bicyclic compound
05/06/2010WO2010050436A1 Piperidine derivative, piperazine derivative and agent for treatment of disease involving central nervous system disorders
05/06/2010WO2010050435A1 Cyclohexylamine derivative containing phenyl group, and therapeutic agent for diseases accompanied by central nervous system disorders
05/06/2010WO2010050422A1 Agent for treatment of diabetes
05/06/2010WO2010050328A1 Tumor metastasis inhibitor
05/06/2010WO2010050211A1 Composition for local anesthesia
05/06/2010WO2010050191A1 1,2-diazetidin-3-one derivative and pharmaceutical agent comprising same
05/06/2010WO2010050179A1 Prophylactic/ameliorating agent for adult diseases comprising 5-aminolevulinic acid, derivative of 5-aminolevulinic acid, or salt of 5-aminolevulinic acid or the derivative of 5-aminolevulinic acid as active ingredient
05/06/2010WO2010050168A1 Solid solution of valine, isoleucine and leucine, and method for producing same
05/06/2010WO2010050167A1 Composition for inducing th2 cell, therapeutic composition for th2-type disease, and use of same
05/06/2010WO2009150543A3 Conjugated vi saccharides
05/06/2010WO2009144278A3 Conglutin-gamma as medicament and diet supplement
05/06/2010US20100114014 Pharmaceutical compositions stabilised in glassy particles
05/06/2010US20100113770 O-substituted hydroxyaryl derivatives
1 ... 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 ... 1564